Table 2 Metastatic site-specific discordance in receptor status.
From: Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution
Organ | ER | PR | HER2 | ||||||
|---|---|---|---|---|---|---|---|---|---|
Discordant | Concordant | Conversion rate | Discordant | Concordant | Conversion rate | Discordant | Concordant | Conversion rate | |
Bone | 17 | 86 | 16.5% | 49 | 46 | 51.6% | 14 | 71 | 16.5% |
Liver | 16 | 64 | 20% | 29 | 41 | 41.4% | 10 | 61 | 14.1% |
Lung | 13 | 63 | 17.1% | 25 | 42 | 37.3% | 9 | 53 | 14.5% |
Brain | 9 | 31 | 22.5% | 10 | 20 | 33.3% | 5 | 33 | 13.2% |
